Pharmacist telemonitoring of antidepressant use: Effects on pharmacist-patient collaboration

Journal of the American Pharmacists Association

Volumn 45, Issue 3, 2005, Pages 344-353

  Rickles, Nathaniel M ^a   Svarstad, Bonnie L ^b   Statz Paynter, Jamie L ^c   Taylor, Leslie V ^d   Kobak, Kenneth A ^d  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c DEAN MEDICAL CENTER   (United States)

^d Dean Found Hlth   (United States)

Author keywords

Adherence; Antidepressant; Community and ambulatory pharmacy; Counseling; Outcomes; Telephone monitoring

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; DRUG USE; HEALTH CARE ORGANIZATION; HUMAN; INFORMATION SERVICE; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PATIENT PARTICIPATION; PHARMACEUTICAL CARE; PHARMACIST; PHARMACIST ATTITUDE; PHARMACY; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; ADULT; AGED; COUNSELING; DEPRESSION; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; TELEPHONE; UNITED STATES;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; COMMUNITY PHARMACY SERVICES; COUNSELING; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; TELEPHONE; WISCONSIN;

EID: 22144485566     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/1544345054003732     Document Type: Article

References (35)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth ed., revised. Washington, D.C.: American Psychiatric Association; 1994.
2. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patient's adherence to antidepressant therapy. Med Care. 1995;33:67-74.
3. Weissman MM, Johnson J. Drug use and abuse in five US communities. NY State J Med. 1991;91:19S-23S.
4. Lepine JP, Gastpar M, Mendlewicz J, Tylee A. Depression in the community: the first pan-European study DEPRESS (Depression Research in European Society). Intl Clin Psychopharmacol. 1997;12:19-29.
5. Angst J. Treated versus untreated major depressive disorder. Psychopathol. 1998;31:37-44.
6. National Depressive and Manic-Depressive Association (NDMDA). Beyond diagnosis: a landmark survey of patients, partners and health professionals on depression and treatment. New York: Schulman, Ronca & Bucuvalas, Inc.; 2000.
7. Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 2002;288:1403-9.
8. Bultman DC, Svarstad BL. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Counsel. 2000;40:173-85.
9. Simon GE, VonKorff M, Rutter C, Wagner E. Randomized trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000;320:550-4.
10. Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58:241-7.
11. Hunkeler EM, Meresman JF, Hargreaves WA, et al. Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch Fam Med. 2000;9:700-8.
12. Tutty S, Simon G, Ludman E. Telephone counseling as an adjunct to antidepressant treatment in the primary care system: a pilot study. Eff Clin Pract. 2000;3:191-3.
13. Bond CA, Salinger RJ. Fluphenazine outpatient clinics: a pharmacist's role. J Clin Psychiatry. 1979;40:501-3.
14. Saklad SR, Ereshefsky L, Jann MW, Crismon ML. Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility. Drug Intell Clin Pharm. 1984;18:632-4.
15. Lobeck F, Traxler WT, Bobiner DD. The cost-effectiveness of a clinical pharmacy service in an outpatient mental health clinic. Hosp Comm Pharm. 1989;40:643-5.
16. Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002;59:1518-26.
17. Bultman DC, Svarstad BL. Effects of pharmacist monitoring on client satisfaction with antidepressant medication. J Am Pharm Assoc. 2002;42:36-43.
18. Svarstad BL, Bultman DC. The patient: behavioral determinants. In: Gennaro AE, ed. Remington's the science and practice of pharmacy, 20th ed. Baltimore: Lippincott Williams & Wilkins, 2000:1948-56.
19. Nola KM, Gourley DR, Portner TS, et al. Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. J Am Pharm Assoc. 2000;40:165-73.
20. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT: hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
21. McKenney JM, Slining JM, Henderson HR, et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973;48:1104-11.
22. McKenney JM, Brown ED, Necsary R, et al. Effect of pharmacist drug monitoring and patient education on hypertensive patients. Contemp Pharm Pract. 1978;1(2):50-6.
23. Berringer R, Shibley MCH, Pugh CB, et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;39:791-7.
24. Narhi U, Airaksinen M, Tanskanen P, et al. Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma. J Clin Pharm Ther. 2000;25:177-83.
25. Beck AT, Steer RA, Brown GK. BDI-II Manual. San Antonio: The Psychological Corporation; 1996.
26. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138-61.
27. Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale, N.J.: Lawrence Erlbaum Associates; 1988.
28. Clinical practice guideline number 5: depression in primary care, vol 2. Treatment of major depression. Rockville, Md.: US Department of Health Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0551.
29. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-334.
30. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074-90.
31. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Counsel. 1999;37:113-24.
32. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13:10-24.
33. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273:1026-31.
34. Fleiss JL Statistical methods for rates and proportions, 2nd ed. New York: John Wiley and Sons, Inc.; 1981.
35. Rothlisberger FI, Dickson WI. Management and the worker. Cambridge, Mass.: Harvard University Press; 1939.